ClinicalTrials.gg
Not yet recruitingNCT07939282Updated Nov 16, 2026

Effect of Ankle Joint Manipulation on Chronic Ankle Sprain With Compressed Ankle Joint for Volleyball and Basketball Players

An interventional study of Ankle joint manipulation (Head of fibula manipulation) in Chronic Ankle Sprain, Compressed Ankle Joint and Chronic Ankle Instability (CAI), sponsored by Kafrelsheikh University. Not yet recruiting. Open to participants aged 16 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
16 Years to 45 Years
Sex
All
01

Study summary

The goal of this pre-post randomized controlled experimental trial is to examine the impact of ankle joint manipulation on chronic ankle sprain with a compressed ankle joint in athletes (identified in the proposal as volleyball, basketball, and tennis players) aged 16 to 45 years of both genders.

The main questions it aims to answer are:

Does ankle joint manipulation effectively reduce pain and improve functional status? Does the treatment successfully increase ankle range of motion (ROM)?

Researchers will compare an experimental group receiving manipulation to a control group receiving no treatment to determine the intervention's effectiveness.

Participants will:

  • Be randomly assigned into two equal groups of 30 patients each.
  • Either receive a one-shot manipulation of the head of the fibula or receive no treatment.
  • Have their ankle range of motion measured using an electronic goniometer.
  • Report their ankle pain levels measured by a numeric analog scale.
  • Complete a functional assessment evaluated by the ankle joint functional index.
02

Conditions studied

  • Chronic Ankle Sprain
  • Compressed Ankle Joint
  • Chronic Ankle Instability (CAI)
  • Lateral Ankle Sprain (LAS)

Browse trials for

Keywords

  • Ankle joint manipulation
  • Head of fibula manipulation
  • Chronic ankle sprain
  • Compressed ankle joint
  • Sports rehabilitation
  • Ankle range of motion
  • Volleyball, basketball, and tennis players
  • Ankle joint functional index
03

In context

Ankle Injuries

353 studies on the registry are indexed under Ankle Injuries; 74 are open to participants now.

This study's planned enrollment of 60 is above the median of 54 across 271 interventional studies indexed under Ankle Injuries.

Browse Ankle Injuries studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 300 studies on the registry; 119 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants must be volleyball, basketball, or tennis players. Participants must have a chronic ankle sprain with a compressed ankle joint. Participants must be within the age range of 16 to 45 years. Participants can be of either gender. Participants must be willing to sign a consent form according to the Helsinki Protocol.

Exclusion criteria

Exclusion Criteria:

  • History of acute severe ankle fractures or previous lower extremity surgeries.
  • Presence of open wounds, skin lesions, or severe dermatological conditions around the ankle or fibula region that contraindicate manual manipulation.
  • Acute systemic inflammatory conditions or arthropathies (such as rheumatoid arthritis or gout).
  • Neurological deficits, severe peripheral neuropathy, or vascular disorders affecting the lower limbs.
  • Receipt of any other physical therapy treatments, injections, or interventions for the ankle within the weeks preceding the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Head of Fibula Manipulation

    Procedure: Ankle joint manipulation (Head of fibula manipulation)

  • No intervention
    Control Group

Interventions

  • ProcedureAnkle joint manipulation (Head of fibula manipulation)

    The intervention consists of a single session ("one shoot") manual manipulation targeting the head of the fibula. This manipulation targets joint compression, often addressing posterior positional faults of the talus, to restore normal arthrokinematics. The procedure is intended to instantly improve dorsiflexion range of motion, reduce anterior impingement pain, and enhance dynamic balance and landing mechanics in athletes.

06

What researchers measure

Primary outcomes

  1. Ankle range of motion measured by an electronic goniometer

    Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

Secondary outcomes

  1. Ankle pain measured by a numeric analog scale

    Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

  2. Ankle function assessed by the ankle joint functional index

    Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — Data will be shared upon reasonable request from the principal investigator.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

Of 140 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 1 month is below that.

Counting every sponsor, half of 143 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 16, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
Dec 10, 2026
CompletionEst.
Dec 11, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07939282
Responsible party
yasmein mohammed mahmoud (Dr, Kafrelsheikh University) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Dec 10, 2026 (estimated)
Completion
Dec 11, 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Yasmein Mohammed Mahmoud, PhD.
Contact
yasmeinyossef@gmail.com
01061344240
Mohammed Abdelaziz Emam, master degree, Ass.lecturer
principal investigator · faculty of physical therapy, kafr elshiekh university
Reda Fathi Elbosaty, Bachelor student
principal investigator · faculty of physical therapy, kafr elshiekh university
Yasmein Mohammed Mahmoud, Ph.D, lecturer
principal investigator · faculty of physical therapy, kafr elshiekh university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion